Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 32
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: NL25655.031.08
Study First Received: September 27, 2010
Last Updated: February 27, 2017
Estimated Primary Completion Date: November 13, 2012
Primary Outcome Measures:
To test the impact of the addition of axitinib to standaard chemotherapy treatment on histology samples|the side effects of the standard chemotherapy and the additional risks related to axitinib use
Sponsors and Collaborators:
The Netherlands Cancer Institute|Pfizer
Website Link: https://ClinicalTrials.gov/show/NCT01211275
